Friday, February 10, 2012

New Rheumatoid Arthritis Drug Enters Phase II Clinical Trial

(Wall Street Journal) UPDATED 2010-08-26
The U.S. Food and Drug Administration has approved the start of a Phase II clinical trial for Chelsea Therapeutics International's new drug for rheumatoid arthritis (RA). Company officials say the trial, which is designed to evaluate the drug's safety and efficacy, is a step toward finding an alternative treatment for RA, which is currently dominated by methotrexate as a standard treatment.
  Read full story >
See all Rheumatoid Arthritis News

People who read this also read...

  • Voltaren Sunblock
  • What Imuran Do You Take For Rheumatoid Arthritis?
  • Sex Gouty Arthritis
  • Sharp Back Pain Rheumatoid Arthritis
  • Plaquenil 200 Magnesium
  • Arthritis Joint Splinting